Vivekanandan-Giri A, Slocum JL, Byun J, Tang C, Sands RL, Gillespie BW, Heinecke JW, Saran R, Kaplan MJ, Pennathur S
Research is ongoing to determine whether these drugs could help protect against neurodegenerative diseases like Alzheimer's
Explore detailed information about tirzepatide treatment
Do not switch too frequently Switching every 2 to 4 weeks does not give either medication enough time to reach steady state or produce meaningful effects
FOXO4-DRI's disruption of FOXO4-p53 interactions specifically targets these survival mechanisms without affecting normal cell cycle regulation in healthy cells, providing researchers with precision tools for studying senescence biology